Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report.

Fields VS, Safi H, Waters C, Dillaha J, Capelle L, Riklon S, Wheeler JG, Haselow DT.

Lancet Infect Dis. 2019 Feb;19(2):185-192. doi: 10.1016/S1473-3099(18)30607-8. Epub 2019 Jan 8.

PMID:
30635255
2.

The molecular landscape of glioma in patients with Neurofibromatosis 1.

D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.

Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10.

PMID:
30531922
3.

Developmental venous anomaly in adult patients with diffuse glioma: A clinically relevant coexistence?

Roux A, Edjlali M, Porelli S, Tauziede-Espariat A, Zanello M, Dezamis E, Zah-Bi G, Sanson M, Puget S, Capelle L, Varlet P, Oppenheim C, Pallud J.

Neurology. 2019 Jan 1;92(1):e55-e62. doi: 10.1212/WNL.0000000000006690. Epub 2018 Nov 30.

PMID:
30504430
4.

Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma.

Still MEH, Roux A, Huberfeld G, Bauchet L, Baron MH, Fontaine D, Blonski M, Mandonnet E, Guillevin R, Guyotat J, Taillandier L, Capelle L, Duffau H, Pallud J.

Neurosurgery. 2018 Nov 5. doi: 10.1093/neuros/nyy481. [Epub ahead of print]

PMID:
30395304
5.

Cognitive impairment and morphological changes after radiation therapy in brain tumors: A review.

Jacob J, Durand T, Feuvret L, Mazeron JJ, Delattre JY, Hoang-Xuan K, Psimaras D, Douzane H, Ribeiro M, Capelle L, Carpentier A, Ricard D, Maingon P.

Radiother Oncol. 2018 Aug;128(2):221-228. doi: 10.1016/j.radonc.2018.05.027. Epub 2018 Jul 2. Review.

PMID:
30041961
6.

Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.

den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCW.

Gut. 2018 Jun 6. pii: gutjnl-2017-314498. doi: 10.1136/gutjnl-2017-314498. [Epub ahead of print]

PMID:
29875257
7.

Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy.

Dossi E, Blauwblomme T, Moulard J, Chever O, Vasile F, Guinard E, Le Bert M, Couillin I, Pallud J, Capelle L, Huberfeld G, Rouach N.

Sci Transl Med. 2018 May 30;10(443). pii: eaar3796. doi: 10.1126/scitranslmed.aar3796.

PMID:
29848662
8.

ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review.

Gareton A, Pierron G, Mokhtari K, Tran S, Tauziède-Espariat A, Pallud J, Louvel G, Meary E, Capelle L, Chrétien F, Varlet P.

J Neuropathol Exp Neurol. 2018 Jul 1;77(7):537-541. doi: 10.1093/jnen/nly039.

PMID:
29788195
9.

Design of a comparative effectiveness randomized controlled trial testing a faith-based Diabetes Prevention Program (WORD DPP) vs. a Pacific culturally adapted Diabetes Prevention Program (PILI DPP) for Marshallese in the United States.

McElfish PA, Long CR, Kaholokula JK, Aitaoto N, Bursac Z, Capelle L, Laelan M, Bing WI, Riklon S, Rowland B, Ayers BL, Wilmoth RO, Langston KN, Schootman M, Selig JP, Yeary KHK.

Medicine (Baltimore). 2018 May;97(19):e0677. doi: 10.1097/MD.0000000000010677.

10.

Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.

Branzoli F, Di Stefano AL, Capelle L, Ottolenghi C, Valabrègue R, Deelchand DK, Bielle F, Villa C, Baussart B, Lehéricy S, Sanson M, Marjanska M.

Neuro Oncol. 2018 Jun 18;20(7):907-916. doi: 10.1093/neuonc/nox214.

PMID:
29126125
11.

Intraoperative Functional Ultrasound Imaging of Human Brain Activity.

Imbault M, Chauvet D, Gennisson JL, Capelle L, Tanter M.

Sci Rep. 2017 Aug 4;7(1):7304. doi: 10.1038/s41598-017-06474-8.

12.

Preoperative and intraoperative neurophysiological investigations for surgical resections in functional areas.

Huberfeld G, Trébuchon A, Capelle L, Badier JM, Chen S, Lefaucheur JP, Gavaret M.

Neurochirurgie. 2017 Jun;63(3):142-149. doi: 10.1016/j.neuchi.2016.10.008. Epub 2017 May 12.

PMID:
28506486
13.

Resection of cavernous angioma located in eloquent areas using functional cortical and subcortical mapping under awake conditions. Outcomes in a 50-case multicentre series.

Zanello M, Wager M, Corns R, Capelle L, Mandonnet E, Fontaine D, Reyns N, Dezamis E, Matsuda R, Bresson D, Duffau H, Pallud J.

Neurochirurgie. 2017 Jun;63(3):219-226. doi: 10.1016/j.neuchi.2016.08.008. Epub 2017 May 12.

PMID:
28502568
14.

Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations.

Vecht C, Duran-Peña A, Houillier C, Durand T, Capelle L, Huberfeld G.

J Neurooncol. 2017 Jul;133(3):603-607. doi: 10.1007/s11060-017-2473-1. Epub 2017 May 10.

PMID:
28492978
15.

Interactions between glioma and pregnancy: insight from a 52-case multicenter series.

Peeters S, Pagès M, Gauchotte G, Miquel C, Cartalat-Carel S, Guillamo JS, Capelle L, Delattre JY, Beauchesne P, Debouverie M, Fontaine D, Jouanneau E, Stecken J, Menei P, De Witte O, Colin P, Frappaz D, Lesimple T, Bauchet L, Lopes M, Bozec L, Moyal E, Deroulers C, Varlet P, Zanello M, Chretien F, Oppenheim C, Duffau H, Taillandier L, Pallud J.

J Neurosurg. 2018 Jan;128(1):3-13. doi: 10.3171/2016.10.JNS16710. Epub 2017 Mar 3.

PMID:
28298039
16.

Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study.

Ursu R, Carpentier A, Metellus P, Lubrano V, Laigle-Donadey F, Capelle L, Guyotat J, Langlois O, Bauchet L, Desseaux K, Tibi A, Chinot O, Lambert J, Carpentier AF.

Eur J Cancer. 2017 Mar;73:30-37. doi: 10.1016/j.ejca.2016.12.003. Epub 2017 Jan 28.

PMID:
28142059
17.

Clinical trial of blood-brain barrier disruption by pulsed ultrasound.

Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C, Karachi C, Leclercq D, Lafon C, Chapelon JY, Capelle L, Cornu P, Sanson M, Hoang-Xuan K, Delattre JY, Idbaih A.

Sci Transl Med. 2016 Jun 15;8(343):343re2. doi: 10.1126/scitranslmed.aaf6086.

PMID:
27306666
18.

K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway.

Joyon N, Tauziède-Espariat A, Alentorn A, Giry M, Castel D, Capelle L, Zanello M, Varlet P, Bielle F.

Neuropathol Appl Neurobiol. 2017 Apr;43(3):271-276. doi: 10.1111/nan.12329. No abstract available.

PMID:
27219822
19.

Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.

Peyre M, Zanello M, Mokhtari K, Boch AL, Capelle L, Carpentier A, Clemenceau S, Karachi C, Navarro S, Nouet A, Reina V, Valery CA, Sanson M, Cornu P, Kalamarides M.

J Neurooncol. 2015 May;123(1):151-60. doi: 10.1007/s11060-015-1778-1. Epub 2015 Apr 17.

PMID:
25894596
20.

In Vivo Measurement of Brain Tumor Elasticity Using Intraoperative Shear Wave Elastography.

Chauvet D, Imbault M, Capelle L, Demene C, Mossad M, Karachi C, Boch AL, Gennisson JL, Tanter M.

Ultraschall Med. 2016 Dec;37(6):584-590. Epub 2015 Apr 15.

21.

Atypical crossmodal emotional integration in patients with gliomas.

Luherne-du Boullay V, Plaza M, Perrault A, Capelle L, Chaby L.

Brain Cogn. 2014 Dec;92C:92-100. doi: 10.1016/j.bandc.2014.10.003. Epub 2014 Nov 1.

PMID:
25463143
22.

Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice.

Rugge M, Capelle LG, Fassan M.

Best Pract Res Clin Gastroenterol. 2014 Dec;28(6):1043-53. doi: 10.1016/j.bpg.2014.09.002. Epub 2014 Sep 28. Review.

PMID:
25439070
23.

Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France.

Darlix A, Zouaoui S, Virion JM, Rigau V, Mathieu-Daudé H, Blonski M, Reyes-Botero G, Bessaoud F, Trétarre B, Bauchet F, Capelle L, Fabbro M, Kerr C, Figarella-Branger D, Duffau H, Taillandier L, Bauchet L.

J Neurooncol. 2014 Dec;120(3):547-55. doi: 10.1007/s11060-014-1585-0. Epub 2014 Aug 24.

PMID:
25151505
24.

Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.

Gállego Pérez-Larraya J, Paris S, Idbaih A, Dehais C, Laigle-Donadey F, Navarro S, Capelle L, Mokhtari K, Marie Y, Sanson M, Hoang-Xuan K, Delattre JY, Mallet A.

Cancer. 2014 Dec 15;120(24):3972-80. doi: 10.1002/cncr.28949. Epub 2014 Aug 19.

25.

Cortical GABAergic excitation contributes to epileptic activities around human glioma.

Pallud J, Le Van Quyen M, Bielle F, Pellegrino C, Varlet P, Cresto N, Baulac M, Duyckaerts C, Kourdougli N, Chazal G, Devaux B, Rivera C, Miles R, Capelle L, Huberfeld G.

Sci Transl Med. 2014 Jul 9;6(244):244ra89. doi: 10.1126/scitranslmed.3008065.

26.

Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.

Gozé C, Blonski M, Le Maistre G, Bauchet L, Dezamis E, Page P, Varlet P, Capelle L, Devaux B, Taillandier L, Duffau H, Pallud J.

Neuro Oncol. 2014 Aug;16(8):1100-9. doi: 10.1093/neuonc/nou085. Epub 2014 May 20.

27.

Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France.

Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daudé H, Rigau V, Fabbro M, Bessaoud F, Taillandier L, Ducray F, Bauchet F, Wager M, Faillot T, Capelle L, Loiseau H, Kerr C, Menei P, Duffau H, Figarella-Branger D, Chinot O, Trétarre B, Bauchet L.

Neurosurg Rev. 2014 Jul;37(3):415-23; discussion 423-4. doi: 10.1007/s10143-014-0528-8. Epub 2014 Feb 14.

PMID:
24526367
28.

Epileptic seizures in diffuse low-grade gliomas in adults.

Pallud J, Audureau E, Blonski M, Sanai N, Bauchet L, Fontaine D, Mandonnet E, Dezamis E, Psimaras D, Guyotat J, Peruzzi P, Page P, Gal B, Párraga E, Baron MH, Vlaicu M, Guillevin R, Devaux B, Duffau H, Taillandier L, Capelle L, Huberfeld G.

Brain. 2014 Feb;137(Pt 2):449-62. doi: 10.1093/brain/awt345. Epub 2013 Dec 27.

PMID:
24374407
29.

Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.

Alentorn A, van Thuijl HF, Marie Y, Alshehhi H, Carpentier C, Boisselier B, Laigle-Donadey F, Mokhtari K, Scheinin I, Wesseling P, Ylstra B, Capelle L, Hoang-Xuan K, Sanson M, Delattre JY, Reijneveld JC, Idbaih A.

Neuro Oncol. 2014 Mar;16(3):400-8. doi: 10.1093/neuonc/not227. Epub 2013 Dec 12.

30.

Tumoral epileptogenicity: how does it happen?

Pallud J, Capelle L, Huberfeld G.

Epilepsia. 2013 Dec;54 Suppl 9:30-4. doi: 10.1111/epi.12440. Review.

31.

The silent phase of diffuse low-grade gliomas. Is it when we missed the action?

Pallud J, Capelle L, Taillandier L, Badoual M, Duffau H, Mandonnet E.

Acta Neurochir (Wien). 2013 Dec;155(12):2237-42. doi: 10.1007/s00701-013-1886-7. Epub 2013 Oct 2.

PMID:
24085316
32.

A case of bilateral frontal tumors without "frontal syndrome".

Plaza M, du Boullay V, Perrault A, Chaby L, Capelle L.

Neurocase. 2014;20(6):671-83. doi: 10.1080/13554794.2013.826696. Epub 2013 Aug 21.

PMID:
23962155
33.

Precancerous lesions in the stomach: from biology to clinical patient management.

Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ.

Best Pract Res Clin Gastroenterol. 2013 Apr;27(2):205-23. doi: 10.1016/j.bpg.2012.12.007. Review.

PMID:
23809241
34.

Identification of genetic loci associated with Helicobacter pylori serologic status.

Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, Capelle LG, Zimmermann K, Rivadeneira F, Gruska S, Völzke H, de Vries AC, Völker U, Teumer A, van Meurs JB, Steinmetz I, Nauck M, Ernst F, Weiss FU, Hofman A, Zenker M, Kroemer HK, Prokisch H, Uitterlinden AG, Lerch MM, Kuipers EJ.

JAMA. 2013 May 8;309(18):1912-20. doi: 10.1001/jama.2013.4350. Erratum in: JAMA. 2013 Jul 3;310(1):99. Kuipers, Ernst [corrected to Kuipers, Ernst J].

PMID:
23652523
35.

Follow-up of premalignant lesions in patients at risk for progression to gastric cancer.

den Hoed CM, Holster IL, Capelle LG, de Vries AC, den Hartog B, Ter Borg F, Biermann K, Kuipers EJ.

Endoscopy. 2013;45(4):249-56. doi: 10.1055/s-0032-1326379. Epub 2013 Mar 26.

PMID:
23533073
36.

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.

Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M, Guyotat J, Guillevin R, Frenay M, Taillibert S, Colin P, Rigau V, Vandenbos F, Pinelli C, Duffau H; French Réseau d'Étude des Gliomes.

J Neurosurg. 2013 Jun;118(6):1157-68. doi: 10.3171/2013.1.JNS121. Epub 2013 Mar 15.

PMID:
23495881
37.

Combined Angio-Seal™ and stenting rescue treatment in a case of iatrogenic common carotid artery dissection during direct puncture for ruptured intracranial aneurysm embolization: a technical note.

Iosif C, Clarençon F, Di Maria F, Law-Ye B, Le Jean L, Capelle L, Chiras J, Sourour N.

J Neuroradiol. 2013 May;40(2):130-3. doi: 10.1016/j.neurad.2012.05.002. Epub 2013 Feb 20.

PMID:
23433677
38.

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, Bauchet L, Peruzzi P, Frénay M, Colin P, Guillevin R, Bernier V, Baron MH, Guyotat J, Duffau H, Taillandier L, Capelle L.

Neuro Oncol. 2013 May;15(5):595-606. doi: 10.1093/neuonc/nos331. Epub 2013 Feb 7.

39.

Evaluation of quantitative criteria for glioma grading with static and dynamic 18F-FDopa PET/CT.

Nioche C, Soret M, Gontier E, Lahutte M, Dutertre G, Dulou R, Capelle L, Guillevin R, Foehrenbach H, Buvat I.

Clin Nucl Med. 2013 Feb;38(2):81-7. doi: 10.1097/RLU.0b013e318279fd5a.

PMID:
23334119
40.

Critical roles for anterior insula and dorsal striatum in punishment-based avoidance learning.

Palminteri S, Justo D, Jauffret C, Pavlicek B, Dauta A, Delmaire C, Czernecki V, Karachi C, Capelle L, Durr A, Pessiglione M.

Neuron. 2012 Dec 6;76(5):998-1009. doi: 10.1016/j.neuron.2012.10.017.

41.

[Identification of emotions in patients with low-grade gliomas versus cerebrovascular accidents].

du Boullay V, Plaza M, Capelle L, Chaby L.

Rev Neurol (Paris). 2013 Mar;169(3):249-57. doi: 10.1016/j.neurol.2012.06.017. Epub 2012 Oct 26. French.

PMID:
23107880
42.

Hemorrhagic papillary glioneuronal tumor mimicking cavernoma: two case reports.

Benzagmout M, Karachi C, Mokhtari K, Capelle L.

Clin Neurol Neurosurg. 2013 Feb;115(2):200-3. doi: 10.1016/j.clineuro.2012.04.021. Epub 2012 Jun 18. No abstract available.

PMID:
22717600
43.

Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates.

Pallud J, Taillandier L, Capelle L, Fontaine D, Peyre M, Ducray F, Duffau H, Mandonnet E.

Neurosurgery. 2012 Sep;71(3):729-39; discussion 739-40. Review.

PMID:
22668885
44.

Skin-sparing helical tomotherapy vs 3D-conformal radiotherapy for adjuvant breast radiotherapy: in vivo skin dosimetry study.

Capelle L, Warkentin H, Mackenzie M, Joseph K, Gabos Z, Pervez N, Tankel K, Chafe S, Amanie J, Ghosh S, Parliament M, Abdulkarim B.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e583-90. doi: 10.1016/j.ijrobp.2012.01.086. Epub 2012 May 12.

PMID:
22580119
45.

Strengths and weaknesses of multimodal processing in a group of adults with gliomas.

Plaza M, Capelle L, Maigret G, Chaby L.

Neurocase. 2013;19(3):302-12. doi: 10.1080/13554794.2012.667128. Epub 2012 May 4.

PMID:
22554225
46.

Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results.

Capelle L, Mackenzie M, Field C, Parliament M, Ghosh S, Scrimger R.

Clin Oncol (R Coll Radiol). 2012 Apr;24(3):208-15. doi: 10.1016/j.clon.2011.11.005. Epub 2011 Dec 22.

PMID:
22196796
47.

Improving the time-machine: estimating date of birth of grade II gliomas.

Gerin C, Pallud J, Grammaticos B, Mandonnet E, Deroulers C, Varlet P, Capelle L, Taillandier L, Bauchet L, Duffau H, Badoual M.

Cell Prolif. 2012 Feb;45(1):76-90. doi: 10.1111/j.1365-2184.2011.00790.x. Epub 2011 Dec 14.

PMID:
22168136
48.

Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case-control study.

Capelle LG, den Hoed CM, de Vries AC, Biermann K, Casparie MK, Meijer GA, Kuipers EJ.

Eur J Gastroenterol Hepatol. 2012 Jan;24(1):42-7. doi: 10.1097/MEG.0b013e32834d85e6.

PMID:
22081006
49.

Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas.

Guillevin R, Menuel C, Abud L, Costalat R, Capelle L, Hoang-Xuan K, Habas C, Chiras J, Vallée JN.

J Magn Reson Imaging. 2012 Mar;35(3):543-50. doi: 10.1002/jmri.22862. Epub 2011 Nov 1.

PMID:
22045581
50.

Differential MRI analysis for quantification of low grade glioma growth.

Angelini ED, Delon J, Bah AB, Capelle L, Mandonnet E.

Med Image Anal. 2012 Jan;16(1):114-26. doi: 10.1016/j.media.2011.05.014. Epub 2011 Jun 6.

PMID:
21911309

Supplemental Content

Loading ...
Support Center